Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv) (CAT#: BSFV-128)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-CD64 antibody variable domains fused with a scFv from an anti-HER2 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv) (BSFV-128). Click the button below to contact us or submit your feedback about this product.